Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2016-01-12 Tx date 2016-01-12 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately
|
$-8,500
-3,400 vol $2.50 each |
5,064,694 | |
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+592,500 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+592,500 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+740,625 vol |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-533,250 vol |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-533,250 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+592,500 vol |
592,500 | |
Filed 2015-11-03 Tx date 2011-09-19 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
57 - Exercise of rights
|
$-18,750,007.50
-15,000,006 vol $1.25 each |
||
Filed 2015-11-03 Tx date 2011-09-19 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
57 - Exercise of rights
|
$-18,750,007.50
-15,000,006 vol $1.25 each |
0 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-45,612,839 vol |
5,068,094 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-533,250 vol |
59,250 | |
Filed 2015-11-03 Tx date 2010-12-31 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants (Séries 3)
55 - Expiration of warrants
|
$-2,832,647.60
-7,081,619 vol $0.40 each |
0 | |
Filed 2015-11-03 Tx date 2011-09-07 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$5,000,000
+4,000,000 vol $1.25 each |
||
Filed 2015-11-03 Tx date 2011-09-07 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$5,000,000
+4,000,000 vol $1.25 each |
4,326,196 | |
Filed 2015-11-03 Tx date 2011-09-08 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$1,804,325
+1,443,460 vol $1.25 each |
||
Filed 2015-11-03 Tx date 2011-09-08 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$1,804,325
+1,443,460 vol $1.25 each |
5,769,656 | |
Filed 2015-11-03 Tx date 2011-09-09 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$11,537,937
+9,230,350 vol $1.25 each |
||
Filed 2015-11-03 Tx date 2011-09-09 |
$APO
Acasti Pharma Inc. |
Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market
|
$11,537,937
+9,230,350 vol $1.25 each |
15,000,006 |